915 related articles for article (PubMed ID: 25589663)
1. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
[TBL] [Abstract][Full Text] [Related]
2. Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques.
Smith SA; Kilgore KM; Kasturi SP; Pulendran B; Hunter E; Amara RR; Derdeyn CA
J Virol; 2016 Feb; 90(4):1880-7. PubMed ID: 26676777
[TBL] [Abstract][Full Text] [Related]
3. The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.
Li Y; Dittmer U; Wang Y; Song J; Sun B; Yang R
Virol Sin; 2016 Jun; 31(3):207-18. PubMed ID: 27117672
[TBL] [Abstract][Full Text] [Related]
4. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
[TBL] [Abstract][Full Text] [Related]
5. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
[TBL] [Abstract][Full Text] [Related]
6. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
Bauer AM; Ziani W; Lindemuth E; Kuri-Cervantes L; Li H; Lee FH; Watkins M; Ding W; Xu H; Veazey R; Bar KJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969435
[TBL] [Abstract][Full Text] [Related]
7. Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C.
Tartaglia LJ; Gupte S; Pastores KC; Trott S; Abbink P; Mercado NB; Li Z; Liu PT; Borducchi EN; Chandrashekar A; Bondzie EA; Hamza V; Kordana N; Mahrokhian S; Lavine CL; Seaman MS; Li H; Shaw GM; Barouch DH
J Virol; 2020 May; 94(10):. PubMed ID: 32132241
[TBL] [Abstract][Full Text] [Related]
8. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
9. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
[TBL] [Abstract][Full Text] [Related]
10. Characterization of founder viruses in very early SIV rectal transmission.
Yuan Z; Ma F; Demers AJ; Wang D; Xu J; Lewis MG; Li Q
Virology; 2017 Feb; 502():97-105. PubMed ID: 28027479
[TBL] [Abstract][Full Text] [Related]
11. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.
Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J
J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649
[TBL] [Abstract][Full Text] [Related]
12. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ
J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953
[TBL] [Abstract][Full Text] [Related]
14. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
15. Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques.
Lamers SL; Nolan DJ; Rife BD; Fogel GB; McGrath MS; Burdo TH; Autissier P; Williams KC; Goodenow MM; Salemi M
J Virol; 2015 Aug; 89(16):8484-96. PubMed ID: 26041280
[TBL] [Abstract][Full Text] [Related]
16. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J
Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956
[TBL] [Abstract][Full Text] [Related]
17. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
Krebs KC; Tian M; Asmal M; Ling B; Nelson K; Henry K; Gibson R; Li Y; Han W; Shattock RJ; Veazey RS; Letvin N; Arts EJ; Gao Y
AIDS Res Ther; 2016 Nov; 13(1):41. PubMed ID: 27906032
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
19. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
20. Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
Imamichi H; Igarashi T; Imamichi T; Donau OK; Endo Y; Nishimura Y; Willey RL; Suffredini AF; Lane HC; Martin MA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13813-8. PubMed ID: 12370415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
